Prognosis for Distressed Healthcare Companies

Distressed Healthcare

M&A Advisor Virtual Summit Series 2020

Gordian Group’s Peter Kaufman participated in The M&A Advisor 2020 Virtual Summit to discussed distressed healthcare. 

Panel: Prognosis for Distressed Healthcare Companies

This recorded interactive session entitled: Prognosis for Distressed Healthcare companies,  provided in-depth analysis on best practices for struggling healthcare companies to streamline operations as well as for buyers looking to acquire health care assets or companies. 

Covered in this recorded session:

  • ​Understand strategies to implement for healthcare companies currently in or approaching Chapter 11
  • Explore valuation and other considerations in asset acquisition
  • Assess trends in M&A activity within the healthcare community

Moderator: Peter Kaufman, President and Head of Restructuring and Distressed M&A, Gordian Group

Panelists: Liam Logue, EVP Global Corporate Development, UDG Healthcare plc | John Tishler, Partner, Waller Law | Emily Johnson is Member with McDonald Hopkins.

Expert Q&A From Panelists

Below is a timestamped breakdown of the interview.

00:00 | Introductions. Learn about the panelists.

02:20 | How do you think COVID is impacting the marketplace?

RELATED: Distressed Healthcare: Survival Tactics and Smart Investing During

04:31 | What regulatory concerns are there on a distressed deal on the buy side vs. the sell side? Do regulatory concerns drive the timing of a deal and if so what’s the affect?

08:55 | What’s the current status in your view for distressed assets in healthcare?

13:40 | What’s the prognosis for the acquisition of distressed healthcare assets for 2021 and beyond?

16:34 | In what way is the US election playing into the market, if at all?

19:30 | Any views on pending Supreme Court case regarding the Affordable Care Act (ACA) impacting the market?

21:41 | What will be the net winners in the next couple of years in distressed healthcare?

ALSO SEE: Healthcare Case Studies

26:42 | What about rural healthcare markets? Any concerns about rural hospitals surviving? Are they worth investing in?

ALSO SEE: Rural and Inner City Hospitals are Not Getting Funds They Need

33:12 | Who are the most likely buyers of healthcare assets? Competitors, opportunistic investors, private equity?

RELATED POSTS: Ways Private Equity Firms Can Deal With Distressed Debt. See scenario two | Report From the Front: Private Equity Restructuring in the COVID Era

 Audience Q&A

36:33 | What should the board of directors of a healthcare company be doing at this time?

RELATED READS: The Distressed Company and the Corporate Officer | Picking the Right Distressed Advisory Team

39:20 | When should the board of a distressed or potentially distressed healthcare company take some sort of action?

41:09 | What regulatory information would a seller need to gather in advance of a sale?

RELATED READS: The 7 Signs of Financial Distress in a Company

Thank you to The M&A Advisor for hosting this webinar, to the participants for their valued insights and to you for watching.

Learn More and Connect With Us

Learn more about our work with healthcare companiesRestructuring and Debt Advisory, additional services and key team membersContact us and follow us on LinkedIn and Twitter.